Indian Army Department Of Military Affairs Pharmaceuticals & Medical Supplies Tender 2026 Rajasthan - ISI/ISO Standards & EMD 2026

Tender Overview

The procurement is issued by the Indian Army under the Department Of Military Affairs for a broad batch of medical and associated items, including injectable drugs, topical solutions, oral tablets, medical equipment like a Walking Stick Tetra pod, and related consumables. The BOQ comprises 20 items covering diverse categories such as injectable medicines, tablets, prefilled injectables, and ambulatory aids, with an undefined total estimated value and no fixed end-user location provided in the data. The tender emphasizes continuity of supply, shelf life requirements, and avoidance of obsolete products, with exclusivity around OEM legitimacy and GOVT-grade procurement compliance. A key differentiator is the emphasis on three-year residual market life and regular government sector experience. The absence of explicit start/end dates or location signals a nationwide or centralized procurement scope within the Indian Army ecosystem. bidders should expect ATC/corrigendum updates and mandatory documentation checks. Unique aspects include shelf-life minima and the need for ongoing supply to government buyers, along with strict anti-obsolescence and GST considerations.

Technical Specifications & Requirements

• No explicit technical specifications provided in the data.
• Items listed include: Triamcinolone Acetate 10 mg/ml Inj; Chloroxylenol solution (various concentrations) with associated solvents; Ethanol-based formulations; Mannitol 20%; Castor Oil; Terpineol; Oleic acid; Prefilled Erenumab 70 mg Inj; Edaravone 60 mg Inj; multiple Tab formulations such as Fludrocortisone 0.1 mg, Pyridostigmine 60 mg, Memantine 10 mg, Duloxetine 20 mg, Praziquantel 600 mg, Naproxen 250 mg + Domperidone 10 mg, Phenytoin Sodium 100 mg; Brivaracetam 50 mg; Quetiapine 50 mg; Pregabalin combinations; Methycobalmine 750 mg; Midodrine 2.5 mg; Amitriptyline 10 mg; walking stick tetra pod; and Ethosuximide oral solution.
• Emphasis on non-obsolescence, shelf life, and OEM/brand legitimacy.
• No explicit ISO/IS standards listed; bidders should rely on standard GMP/Pharma sector norms and gov’t procurement guidelines.
• Delivery approach and testing requirements are unspecified; bidders should anticipate ATC and technical evaluation samples as per ATC clause.

Terms, Conditions & Eligibility

• EMD and exact amount not specified in the data; bidders must refer to the bid document and ATC for exact figures.
• Eligibility requires: 3 years of regular manufacturing/supply to Central/State Govt/PSU for same or similar products; copies of contracts to be provided.
• Shelf life requirement: minimum usable shelf life remaining at receipt must be at least 5/6th of total shelf life.
• Documentation: PAN, GSTIN, canceled cheque, EFT mandate; GST applicability to be confirmed by bidder.
• Delivery terms, extension with LDs, and demurrage provisions exist but specific percentages/dates are partially defined (e.g., demurrage 0.5% per day for unlifted goods).
• Taxes: supplier bears toll/entry taxes unless otherwise paid; payment terms and penalties are to be defined in the rate contract.
• Samples may be required during technical evaluation; non-submission of certificates may lead to rejection.
• The order placement is rate-based and subject to buyer’s separate orders as per requirement.